nach oben

Erschienen in:

27.02.2018 | Original Article

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience

verfasst von: Firas G. Petros, Michael J. Metcalfe, Kai-Jie Yu, Sarp K. Keskin, Bryan M. Fellman, Courtney M. Chang, Cindy Gu, Pheroze Tamboli, Surena F. Matin, Jose A. Karam, Christopher G. Wood

Erschienen in: World Journal of Urology | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate oncologic outcomes and management of patients with microscopic positive surgical margin (PSM) after partial nephrectomy (PN) for renal cell carcinoma (RCC).

Methods

We reviewed our database to identify patients who underwent PN between 1990 and 2015 for RCC and had PSM on final pathology. A 1:3 matching was performed to a negative surgical margin (NSM) cohort. Kaplan–Meier method and log-rank test were used to estimate survival and differences in outcomes, respectively. Cox proportional hazards models were conducted to estimate the Hazards ratio.

Results

A total of 2297 patients underwent PN at our institution, of which 1863 (81%) had RCC. Microscopic PSM was found in 34 (1.8%) RCC patients who were matched to 100 patients with NSM. Of these 34 patients, local recurrence (n = 4), distant kidney recurrences (n = 4), and metastases (n = 5) developed during a median follow-up of 62 months. Bilateral tumors/tumors in a solitary kidney (n = 12/13, 92%), and multifocal tumors (n = 7/13, 54%) were found in patients who developed recurrence/metastasis. PSM patients were at a higher risk of shorter overall survival (p = 0.001), local recurrence-free survival (p = 0.003), distant recurrence-free survival (p = 0.032) and metastasis-free survival (p = 0.018). There was statistically significant association between PSM and bilateral tumors, prior treated RCC at presentation and higher nephrometry score in multivariable model.

Conclusions

There was a low rate of microscopic PSM in our large cohort of patients undergoing PN despite tumor complexity. Higher nephrometry score, bilateral tumors, and prior treated RCC independently predicted PSM which showed worse survival, recurrence and metastasis compared to patients with NSM.

Fergany AF, Hafez KS, Novick AC (2000) Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol 163(2):442–445. https://doi.org/10.1016/S0022-5347(05)67896-2 CrossRefPubMed

Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P (2006) Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study. Lancet Oncol 7(9):735–740. https://doi.org/10.1016/s1470-2045(06)70803-8 CrossRefPubMedPubMedCentral

Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, Kuczyk MA, Lam T, Marconi L, Merseburger AS, Mulders P, Powles T, Staehler M, Volpe A, Bex A (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol 67(5):913–924. https://doi.org/10.1016/j.eururo.2015.01.005 CrossRefPubMed

Yossepowitch O, Thompson RH, Leibovich BC, Eggener SE, Pettus JA, Kwon ED, Herr HW, Blute ML, Russo P (2008) Positive surgical margins at partial nephrectomy: predictors and oncological outcomes. J Urol 179(6):2158–2163. https://doi.org/10.1016/j.juro.2008.01.100 CrossRefPubMedPubMedCentral

Khalifeh A, Kaouk JH, Bhayani S, Rogers C, Stifelman M, Tanagho YS, Kumar R, Gorin MA, Sivarajan G, Samarasekera D, Allaf ME (2013) Positive surgical margins in robot-assisted partial nephrectomy: a multi-institutional analysis of oncologic outcomes (leave no tumor behind). J Urol 190(5):1674–1679. https://doi.org/10.1016/j.juro.2013.05.110 CrossRefPubMed

Shah PH, Moreira DM, Okhunov Z, Patel VR, Chopra S, Razmaria AA, Alom M, George AK, Yaskiv O, Schwartz MJ, Desai M, Vira MA, Richstone L, Landman J, Shalhav AL, Gill I, Kavoussi LR (2016) Positive surgical margins increase risk of recurrence after partial nephrectomy for high risk renal tumors. J Urol 196(2):327–334. https://doi.org/10.1016/j.juro.2016.02.075 CrossRefPubMed

Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Pineiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ (2010) Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol 57(3):466–471. https://doi.org/10.1016/j.eururo.2009.03.048 CrossRefPubMed

Kwon EO, Carver BS, Snyder ME, Russo P (2007) Impact of positive surgical margins in patients undergoing partial nephrectomy for renal cortical tumours. BJU Int 99(2):286–289. https://doi.org/10.1111/j.1464-410x.2006.06623.x CrossRefPubMed

Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knuchel R, Madersbacher S, Patard JJ, Van Poppel H (2012) Positive surgical margins after nephron-sparing surgery. Eur Urol 61(4):757–763. https://doi.org/10.1016/j.eururo.2011.11.028 CrossRefPubMed

10.

Kutikov A, Uzzo RG (2009) The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol 182(3):844–853. https://doi.org/10.1016/j.juro.2009.05.035 CrossRefPubMed

11.

Uzzo RG, Novick AC (2001) Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 166(1):6–18CrossRefPubMed

12.

Gill IS, Desai MM, Kaouk JH, Meraney AM, Murphy DP, Sung GT, Novick AC (2002) Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J Urol 167(2 Pt 1):467–469 (discussion 475–466)

13.

Petros FG, Rogers CG (2010) Computer-assisted robotic renal surgery. Ther Adv Urol 2(3):127–132CrossRefPubMedPubMedCentral

14.

Petros F, Sukumar S, Haber GP, Dulabon L, Bhayani S, Stifelman M, Kaouk J, Rogers C (2012) Multi-institutional analysis of robot-assisted partial nephrectomy for renal tumors > 4 cm versus </= 4 cm in 445 consecutive patients. J Endourol Endourol Soc 26(6):642–646. https://doi.org/10.1089/end.2011.0340 CrossRef

15.

Song J, Kim E, Mobley J, Vemana G, Tanagho Y, Vetter J, Bhayani S, Russo P, Fugita O, Yang SS, Iwamura M, Figenshau RS (2014) Port site metastasis after surgery for renal cell carcinoma: harbinger of future metastasis. J Urol 192(2):364–368. https://doi.org/10.1016/j.juro.2014.02.089 CrossRefPubMed

16.

Russo P (2000) Renal cell carcinoma: presentation, staging, and surgical treatment. Semin oncol 27(2):160–176PubMed

17.

Sutherland SE, Resnick MI, Maclennan GT, Goldman HB (2002) Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol 167(1):61–64CrossRefPubMed

18.

Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC (2011) Comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. J Urol 185(2):421–427. https://doi.org/10.1016/j.juro.2010.09.131 CrossRefPubMed

19.

Khemees TA, Lam ET, Joehlin-Price AS, Mortazavi A, Phillips GS, Shabsigh A, Sharp DS, Zynger DL (2016) Does the renal parenchyma adjacent to the tumor contribute to kidney function? A critical analysis of glomerular viability in partial nephrectomy specimens. Urology 87:114–119. https://doi.org/10.1016/j.urology.2015.10.018 CrossRefPubMed

20.

Minervini A, Ficarra V, Rocco F, Antonelli A, Bertini R, Carmignani G, Cosciani Cunico S, Fontana D, Longo N, Martorana G, Mirone V, Morgia G, Novara G, Roscigno M, Schiavina R, Serni S, Simeone C, Simonato A, Siracusano S, Volpe A, Zattoni F, Zucchi A, Carini M (2011) Simple enucleation is equivalent to traditional partial nephrectomy for renal cell carcinoma: results of a nonrandomized, retrospective, comparative study. J Urol 185(5):1604–1610. https://doi.org/10.1016/j.juro.2010.12.048 CrossRefPubMed

21.

Schiavina R, Serni S, Mari A, Antonelli A, Bertolo R, Bianchi G, Brunocilla E, Borghesi M, Carini M, Longo N, Martorana G, Mirone V, Morgia G, Porpiglia F, Rocco B, Rovereto B, Simeone C, Sodano M, Terrone C, Ficarra V, Minervini A (2015) A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian Project. Clin Genitourin Cancer 13(2):165–170. https://doi.org/10.1016/j.clgc.2014.08.008 CrossRefPubMed

22.

Puppo P, Introini C, Calvi P, Naselli A (2004) Long term results of excision of small renal cancer surrounded by a minimal layer of grossly normal parenchyma: review of 94 cases. Eur Urol 46(4):477–481. https://doi.org/10.1016/j.eururo.2004.07.007 CrossRefPubMed

23.

Borghesi M, Brunocilla E, Schiavina R, Martorana G (2013) Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer 11(1):5–9. https://doi.org/10.1016/j.clgc.2012.09.010 CrossRefPubMed

24.

Duvdevani M, Laufer M, Kastin A, Mor Y, Nadu A, Hanani J, Nativ O, Ramon J (2005) Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J Urol 173(2):385–387. https://doi.org/10.1097/01.ju.0000149111.48445.73 CrossRefPubMed

25.

Terai A, Ito N, Yoshimura K, Ichioka K, Kamoto T, Arai Y, Ogawa O (2004) Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. Eur Urol 45(6):744–748. https://doi.org/10.1016/j.eururo.2004.02.007 CrossRefPubMed

26.

Zhang C, Xu Y, Zhang Z, Qiao B, Yang K, Liu R, Ma B (2012) Laparoscopic simple enucleation and coagulation on tumor bed using argon beam coagulator for treating small renal cell carcinomas: an animal study followed by clinical application. Med Sci Monit 18(5):193–197CrossRef

27.

Sundaram V, Figenshau RS, Roytman TM, Kibel AS, Grubb RL 3rd, Bullock A, Benway BM, Bhayani SB (2011) Positive margin during partial nephrectomy: does cancer remain in the renal remnant? Urology 77(6):1400–1403. https://doi.org/10.1016/j.urology.2010.12.016 CrossRefPubMed

Titel: Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience
verfasst von: Firas G. Petros
Michael J. Metcalfe
Kai-Jie Yu
Sarp K. Keskin
Bryan M. Fellman
Courtney M. Chang
Cindy Gu
Pheroze Tamboli
Surena F. Matin
Jose A. Karam
Christopher G. Wood
Publikationsdatum: 27.02.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 7/2018
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-018-2241-7

Neu im Fachgebiet Urologie

25.04.2024 | Nierenkarzinom | Nachrichten

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2018

Dual-centre randomized-controlled trial comparing transurethral endoscopic enucleation of the prostate using diode laser vs. bipolar plasmakinetic for the treatment of LUTS secondary of benign prostate obstruction: 1-year follow-up results

YRNA expression in prostate cancer patients: diagnostic and prognostic implications

A new treatment of female stress urinary incontinence with vaginal antetheca–retropubic space mesh repair surgery: a clinical trial

Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients

Robot-sewn ileoileal anastomosis during robot-assisted cystectomy

Mesenchymal stem cells inhibit hypoxia-induced inflammatory and fibrotic pathways in bladder smooth muscle cells

Neu im Fachgebiet Urologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

Stufenschema weist Prostatakarzinom zuverlässig nach

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Urologie